Amphastar Pharmaceuticals (AMPH) Acquisitions (2014 - 2016)

Amphastar Pharmaceuticals' Acquisitions history runs 3 years deep, the most recent figure standing at $3.4 million for Q4 2016.

• On a quarterly basis, Acquisitions fell 2.86% year-over-year to $3.4 million in Q4 2016; TTM through Dec 2016 was $12.4 million, a N/A change from a year earlier, with the FY2016 full-year figure at $12.5 million, up 256.03% from the prior year.
• Acquisitions climbed to $3.4 million in Q4 2016 per AMPH's latest filing, from $761000.0 in the prior quarter.
• Across five years, Acquisitions topped out at $6.0 million in Q4 2014 and bottomed at $761000.0 in Q2 2016.
• The 3-year median for Acquisitions is $3.5 million (2015), against an average of $3.7 million.
• Across the five-year window, Acquisitions slumped 41.67% in 2015 and decreased 2.86% in 2016, its largest moves.
• Year by year, Acquisitions stood at $6.0 million in 2014, then plunged by 41.67% to $3.5 million in 2015, then declined by 2.86% to $3.4 million in 2016.
• Per Business Quant, the three latest AMPH Acquisitions figures stand at $3.4 million (Q4 2016), $761000.0 (Q2 2016), and $4.8 million (Q1 2016).